PA32540

DRUG5 trials

Sponsors

POZEN

Conditions

Aspirin-Associated Gastric UlcersGastric UlcerHealthy

Phase 1

Evaluate Relative Bioavailability of PA32540 (Asa/Omeprazole), Its Aspirin Component, and Ecotrin® in Healthy Volunteers

CompletedNCT00632086

Start: 2008-02-29End: 2008-02-29Target: 36Updated: 2008-03-10

Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib

CompletedNCT00700687

Start: 2008-06-30End: 2008-07-31Target: 90Updated: 2009-01-12

Phase 3

Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

CompletedNCT00960869

POZENGastric Ulcer

Start: 2009-10-31End: 2012-02-29Updated: 2016-02-17

A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

CompletedNCT00961350

POZENGastric Ulcer

Start: 2009-10-31End: 2012-02-29Updated: 2016-02-18

Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers

CompletedNCT00995410

POZENAspirin-Associated Gastric Ulcers

Start: 2009-10-31End: 2011-05-31Updated: 2016-02-17